Catalyst
Slingshot members are tracking this event:
Roche (RHHBY) Phase 3 APHINITY Results Expected in Q1 2017 Evaluating Perjeta in Adjuvant Breast Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RHHBY |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 02, 2017
Occurred Source:
http://www.roche.com/media/store/releases/med-cor-2017-03-02.htm
Related Projects
Related Keywords
Phase 3, Aphinity, Perjeta, Adjuvant Breast Cancer
